PRGDWR-尿激酶原双功能嵌合分子的性质研究  

Characterization of Bifunctional Chimeric Molecule of PRGDWR Containing Pro-Urokinase

作　　者：党昕[1] 杨晶鑫[1] 茹强[1] 茹炳根[1] 

机构地区：[1]北京大学生命科学学院

出　　处：《生物化学与生物物理进展》2001年第2期203-209,共7页Progress In Biochemistry and Biophysics

摘　　要：为赋予单链尿激酶型纤溶酶原激活剂 (singlechainurokinase typeplasminogenactivator,scu PA ,尿激酶原 )以抗血小板聚集的功能 ,在scu PA的kringle区 118位Gly与 119位Leu之间插入PRGDWR序列 (insertmutantB ,InB) .利用甲醇酵母 (Pichiapastoris)进行分泌表达 ,经金属离子螯合亲和层析与S强阳离子交换层析 ,得到纯蛋白 .实验测定InB对人工合成底物S 2 44 4的酰胺解活性为 5 90 0IU/mg ,动力学常数为 :KInBm ,S 2 4 44 =5 6 8μmol·L-1,kInBcat,S 2 4 44 =0 33s-1;水解天然底物 plasminogen的动力学常数为 :KInBm ,plg=0 397μmol·L-1,kInBcat,plg=0 0 16 4s-1.InB激活 plasminogen的反应在有fibrin存在条件下InB的活性为无fibrin条件下的 46 3% .该突变体在体外激活 plasminogen的活性与同一系统表达的野生型scu PA基本相同 .该突变体表现出较强的抗血小板聚集活性 ,IC50 =12 7μmol·L-1,而野生型scu PA无此功能 .实验表明scu PA的K区插入突变体InB是一种极具潜力的双功能溶栓分子 .In order to obtain the bifunctional chimeric molecule of single-chain urokinase-type plasminogen activator (scu-PA) which can inhibit platelet aggregation, PRGDWR peptide was inserted into the site between Gly(118) and Leu(119) (called insertion mutant B, InB). The recombinant gene of InB was expressed by Pichia pastoris. The secreted protein was purified by metal chelate affinity and strong cation exchange chromatography. The amidolytic ability of mutant InB is 5 900 IU/mg, the kinetic constants is: K-m,plg(InB) = 56.8 mu mol.L-1, k(cat,plg)(InB) = 0.33 s(-1). The kinetic constants of plasminogen activation reaction is: exchange K-m,plg(InB) = 0.397 mu mol.L-1, k(cat,plg)(InB) = 0.0164 s(-1). Fibrin inhibit the catalytiv ability of InB during plasminogen activation, the influence factor is 0.463 (means InB remain 46.3% of the catalytic ability when fibrin was involved in the reaction system). The mutant not only has almost the same catalytic ability as wild type scu-PA, but also has strong. ability of anti-platelet aggregation (compared with scu-PA), IC50 of InB is 12.7 mu mol.L-1.

关 键 词：PRGDWR片段 尿激酶原 溶栓活性 血小板聚集 双功能嵌合分子 重组 表达 

分 类 号：Q781[生物学—分子生物学] R973.2[医药卫生—药品]